HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Summary on Jun 27, 2018

June 27, 2018 - By Joseph March

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Corporate Logo

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Coverage

In total 2 analysts cover HTG Molecular Diagnostics (NASDAQ:HTGM). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NASDAQ:HTGM) has 100% bullish analysts. 11 are the (NASDAQ:HTGM)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. The stock rating was maintained by H.C. Wainwright with “Buy” on Tuesday, May 22. On Friday, March 23 the rating was maintained by H.C. Wainwright with “Buy”. In Tuesday, April 17 report H.C. Wainwright maintained the stock with “Buy” rating. In Thursday, February 1 report H.C. Wainwright maintained it with “Buy” rating and $6.0 target. On Friday, June 8 the firm earned “Buy” rating by H.C. Wainwright. On Tuesday, May 8 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. The stock rating was maintained by Canaccord Genuity with “Buy” on Monday, January 8. The company rating was maintained by Canaccord Genuity on Friday, March 23. The company rating was maintained by Canaccord Genuity on Friday, January 5. On Friday, January 5 H.C. Wainwright maintained the shares of HTGM in report with “Buy” rating. Listed here are HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) PTs and latest ratings.

08/06/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
22/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
08/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
17/04/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
23/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $5 New Target: $7 Maintain
23/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
01/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
24/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
08/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain
05/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain

HTGM touched $3.325 during the last trading session after $0.055 change.HTG Molecular Diagnostics, Inc. has volume of 149,326 shares. Since June 27, 2017 HTGM has risen 3.13% and is uptrending. HTGM underperformed by 9.44% the S&P 500.

HTG Molecular Diagnostics, Inc. develops and markets services and products based on proprietary technology that facilitates the routine use of targeted molecular profiling.The firm is worth $94.33 million. The companyÂ’s products, HTG Edge and HTG EdgeSeq platforms include instrumentation , consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.Last it reported negative earnings. The Company’s platforms generate a molecular profiling library for detection using next-generation sequencing.

There’s a significant HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) news published by Seekingalpha.com. It’s an article titled: “HTG Molecular: Entering Stage Of Growth And Momentum” on June 11, 2018.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: